Skip to main content
N
Senior

Senior Clinical Scientist, Adaptive Deep Brain Stimulation (aDBS)

North America or Europe
1 opening
Added to reccy 1d ago
Live on their careers page · checked 1d ago

Send me jobs like this

Weekly, no account needed. We'll ask you to confirm first. Unsubscribe anytime.

About the Role

North America or Europe Full-Time Clinical Affairs / Medical Affairs / R&D Clinical Strategy Level: Senior, Individual Contributor ‍ Travel: Approximately 20% (domestic and international) Role Overview Newronika is seeking a Senior Clinical Scientist to lead the scientific evaluation of new clinical applications for our adaptive Deep Brain Stimulation (aDBS) platform beyond Parkinson’s disease.

Key Responsibilities

  • Synthesize the global neuroscience literature, congress proceedings, ongoing trials, and competitive landscape across DBS, aDBS, BCI, pharmaceutical advancements, and broader neuromodulation.
  • Conduct targeted literature reviews to identify candidate neural biomarkers (e.g., LFP, EEG, neurochemical, behavioral) for new indications, evaluating their feasibility as targets for closed-loop adaptive stimulation.
  • Develop and document mechanistic hypotheses about the plausibility and projected efficacy of adaptive DBS in new indications, integrating insights from neurophysiology, circuit-level pathophysiology, and existing clinical evidence.
  • Evaluate potential applications of DBS/aDBS beyond Parkinson’s disease, including movement disorders, severe neurological conditions and selected neurodegenerative diseases.
  • Map consolidated, emerging and exploratory indications, assessing clinical rationale and level of evidence.
  • Identify relevant KOLs, clinical centers, research groups and ongoing clinical studies.
  • Prepare scientific summaries, landscape analyses, literature reviews and internal clinical-strategic reports.
  • Support discussions with neurologists, neurosurgeons, researchers and scientific advisory boards.
  • Support the Clinical Research and Medical Affairs teams in trial design, scientific protocol input, evidence-generation strategy, and publication planning as new indications mature toward clinical development.
  • Contribute to the definition of a clinical-scientific roadmap for potential new indications.
  • Required Profile
  • Ph.D. in neuroscience, neurology, biomedical engineering, or a closely related discipline is strongly preferred. Equivalent advanced education or substantive applied research experience in neurology, neurosurgery, neuroscience, biomedical engineering, or neuromodulation will also be considered.
  • Experience in neurological, neurosurgical, neurophysiology, neuromodulation or neurotechnology environments.
  • Knowledge of neurostimulation, neurosurgical devices or implantable neurological technologies.
  • Ability to understand clinical workflows, patient pathways, implant procedures, follow-up and therapy management.

About Newronika

Newronika is an Italian medical technology company developing adaptive deep brain stimulation for Parkinson’s disease and other neurological conditions. Its αDBS system records brain signals and adjusts stimulation in real time, with CE-marked commercial availability in the European Economic Area and investigational status in the United States.

HQ
Milan, Italy
Team
11–50
Founded
2008
Raised
$28M
Last round
Series B

Backed by Tech e Biomedical, ENEA Tech e Biomedical, Fondazione ENEA Tech e Biomedical

Newronika in the Cortex

Newronika on reccy
NeuroTechnologyMedical DevicesDigital HealthBiotech

Why Join

  • Uses adaptive, closed-loop stimulation that responds to patients’ neural signals in real time.
  • Builds on more than 20 years of research and development.
  • Spun off from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and the University of Milan.
  • αDBS is CE-marked and commercially available in the European Economic Area.

Benefits

  • A high-impact, founding-era scientific role at a category leader in adaptive (closed-loop) DBS – one of the most active frontier areas in neuromodulation today.
  • Direct ownership of the scientific case for Newronika’s pipeline beyond Parkinson’s disease – shaping which indications are pursued and how.
  • Deep engagement with leading neurologists, neurosurgeons, and academic researchers at top global DBS and neuromodulation centers.
  • Direct collaboration with Newronika’s clinical, regulatory, R&D, and executive leadership in Milan.
  • Access to one of the field’s richest curated neural-data assets (WebBioBank) to inform hypothesis development and biomarker discovery.
  • Fully remote work flexibility within the United States, with periodic travel to Newronika headquarters in Milan.

Skills & Tech

Deep Brain StimulationParkinson's DiseaseBrain-Computer InterfaceElectroencephalography

Know someone perfect for this role?

Share this opportunity with your network